Novel phenyl triazole-pyridylpiperazine derivatives were synthesized & tested against cancer cells. Compounds 15 & 18 showed potent anticancer activity comparable to doxorubicin, with favorable ADME profiles & stable EGFR binding.
Malah et al. (Thu,) studied this question.